Ultima Genomics
Eti has over 18 years of experience in various leadership roles, most recently as VP of Research & Development at Rosetta Genomics. There she led the development of novel platform technologies for oncological and heart disease diagnostics, resulting in the launch of five molecular tests which have been used in the treatment of cancer patients. Eti’s experience also includes guiding and supervising Rosetta's clinical CAP-certified laboratory in Philadelphia. During her career Eti has authored 30 publications in scientific journals and is an inventor on numerus patents or patent applications in the fields of qPCR, microarrays, and oncology biomarkers. She received a PhD from the Weizmann Institute of Science and an MSc from the Hebrew University of Jerusalem.
This person is not in the org chart
This person is not in any offices
Ultima Genomics
4 followers
Ultima Genomics is unleashing the power of genomics at scale. Their mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies.